| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 05/23/1995 | CA1335624C Synthetic aluminum silicate preparation |
| 05/18/1995 | WO1995013080A1 Application of trace elements to animals |
| 05/18/1995 | WO1995013057A1 Antimicrobial method and cosmetic composition |
| 05/17/1995 | EP0652760A1 Therapeutic methods using caesium ions |
| 05/17/1995 | EP0652759A1 Ibuprofen-antacid combinations |
| 05/17/1995 | EP0652743A1 Oral compositions. |
| 05/17/1995 | EP0510158B1 Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and metal salts |
| 05/17/1995 | CN1102568A Tooth disease poder |
| 05/16/1995 | US5415878 Slow release compositions |
| 05/16/1995 | US5415865 Means having microbial effect and little or completely abolished tendency to develop contact allergic reactions or toxic effects and use thereof in e.g. skin and wound treatment products |
| 05/11/1995 | WO1995012406A1 Use of urinastatin-like compounds to prevent premature delivery |
| 05/11/1995 | WO1995012392A1 Biochemically active agents for chemical catalysis and cell receptor activation |
| 05/11/1995 | DE4421686A1 Liposomes containing bioavailable iron(II) and process for their preparation |
| 05/11/1995 | DE4340272C1 Pharmaceutical composition for the optimised treatment of Alzheimer's disease and for preventing progression of this disease |
| 05/11/1995 | CA2175328A1 Use of urinastatin-like compounds to prevent premature delivery |
| 05/11/1995 | CA2174244A1 Biochemically active agents for chemical catalysis and cell receptor activation |
| 05/10/1995 | EP0651641A1 Novel bioactive compositions, preparation and use thereof |
| 05/10/1995 | EP0651637A1 Control of wound scar production with calcium antagonists alone or in a combination with a steroid |
| 05/10/1995 | CN1102348A Water insoluble manganese particles as magnetic resonance contrast enhancement agents |
| 05/10/1995 | CN1102324A Pharmaceutical composition |
| 05/09/1995 | US5413774 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 05/03/1995 | EP0650374A1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant |
| 05/03/1995 | EP0650365A1 Biocidal composition containing mustard seed plant extract. |
| 05/03/1995 | CN1102107A Gucixiao capable of removing spur and preparation technology thereof |
| 05/02/1995 | CA2097337A1 Jesalt - herbal oil canada |
| 04/27/1995 | WO1995011048A2 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO) |
| 04/27/1995 | WO1995011034A1 Composition for weight reduction containing ephedrine and a mineral salt or chelate |
| 04/27/1995 | WO1995011033A1 Polyoxometallates in the treatment of flavivirus infections |
| 04/27/1995 | DE4336642A1 Use of vanadium compounds for the production of pharmaceuticals with an antiviral action |
| 04/27/1995 | CA2174422A1 Composition for weight reduction containing ephedrine and a mineral salt or chelate |
| 04/26/1995 | EP0649662A1 Biodegradable implant precursor |
| 04/26/1995 | EP0649658A1 Method of tumor treatment |
| 04/26/1995 | EP0649310A1 Stable, anticorrosive peracetic/peroxide sterilant |
| 04/26/1995 | EP0649309A1 Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases |
| 04/26/1995 | EP0649274A1 Aqueous compositions comprising an organic peroxiacid |
| 04/26/1995 | CN1101938A Shengongsanfa wine |
| 04/25/1995 | US5409903 Removal of bicarbonate, ammonium compounds, or urea from environment to deactivate bacteria |
| 04/25/1995 | US5409709 Antipyretic analgesic preparation containing ibuprofen |
| 04/25/1995 | US5409690 Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol |
| 04/20/1995 | WO1995010290A1 Antacid pharmaceutical composition |
| 04/20/1995 | WO1995010289A1 Use of lithium compounds for treating high blood pressure |
| 04/20/1995 | DE4335454A1 Geriatric medical composition |
| 04/20/1995 | DE4335441A1 Preventive medical composition for the human cardiovascular system |
| 04/20/1995 | DE4335406A1 Pharmaceutical composition with analgesic and antipruritic activity |
| 04/20/1995 | CA2168959A1 Antacid pharmaceutical composition |
| 04/19/1995 | EP0648126A1 Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach cancer and breast cancer |
| 04/19/1995 | EP0648122A1 PREVENTING TISSUE ADHESION USING -i(IN SITU) MODIFICATION OF ALGINATE. |
| 04/19/1995 | EP0648108A1 Prophylactic and therapeutical preparation against caries. |
| 04/19/1995 | EP0580803A4 Antimicrobial compositions useful for medical applications. |
| 04/19/1995 | EP0518897B1 Oral-hygiene/dentifrice preparations which protect dental enamel |
| 04/19/1995 | CN1101552A External medicine for curing tinea versicolour and its preparation |
| 04/19/1995 | CN1101502A Emulsifying technology for normal milk and beastings of cow |
| 04/18/1995 | US5407924 Method of treating pain using inositol triphosphate |
| 04/18/1995 | US5407688 Compositions and methods for treating gastrointestinal disorders |
| 04/18/1995 | US5407428 Solutions for use as plasma expanders and substitutes |
| 04/18/1995 | CA2113634C Dental tray |
| 04/13/1995 | WO1995009617A1 Controlled release potassium dosage form |
| 04/13/1995 | CA2172624A1 Controlled release potassium dosage form |
| 04/12/1995 | EP0647145A1 Storing stable bicarbonate solutions |
| 04/12/1995 | EP0647130A1 Method of hemodialysis and hemodialysis liquids including hydrochloric acid |
| 04/12/1995 | CN1101263A Iodine content mineral water |
| 04/12/1995 | CN1101262A Antidiabetic agent |
| 04/12/1995 | CN1101261A Preparation of medicine cream for curing burn |
| 04/12/1995 | CN1101260A Material for adjusting function of biology |
| 04/11/1995 | US5405742 Contains purge and maintenance solutions; infusing organ to be transplanted with maintenance solution |
| 04/11/1995 | US5405620 Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin |
| 04/06/1995 | WO1995009003A1 Compositions containing growth factors and antimetabolites |
| 04/06/1995 | WO1995008997A1 Ranitidine and calcium carbonate pharmaceutical combination product |
| 04/06/1995 | WO1995008985A1 Perfluorocarbons as anti-inflammatory agents |
| 04/06/1995 | CA2172601A1 Perfluorocarbons as anti-inflammatory agents |
| 04/06/1995 | CA2168846A1 Ranitidine and calcium carbonate pharmaceutical combination product |
| 04/06/1995 | CA2149528A1 Compositions containing growth factors and antimetabolites |
| 04/05/1995 | EP0646586A1 2-aminoethanesulfonic acid/zinc complex compound |
| 04/05/1995 | EP0646379A1 Insulin formulation |
| 04/04/1995 | US5403921 Drinking a solution of glycerol and water two hours before exertion and continuing until one-half hour before starting; phsiological effects |
| 04/04/1995 | US5403831 Method of treating and preventing loss of bone mass using 1α-hydroxy-vitamin D2 |
| 04/04/1995 | US5403830 Compositions and methods of treating gastrointestinal disorders |
| 04/04/1995 | US5403598 Charging pressure reactor containing tear mixture with carbon dioxide and mixing to equilibrate and maintain bicarbonate |
| 04/04/1995 | US5403578 Aids in preventing periodontal disease, includes urea, calcium peroxide |
| 03/30/1995 | WO1995008350A1 REGULATION OF bcl-2 GENE EXPRESSION |
| 03/29/1995 | EP0645142A1 A novel physiologically active substance |
| 03/29/1995 | EP0645141A1 Treating water for dermatoses in domestic animals |
| 03/29/1995 | EP0644767A1 Veterinary rehydration product. |
| 03/29/1995 | EP0644766A1 Nitrous oxide containing dermatological composition |
| 03/29/1995 | EP0644751A1 Mouthwash for treating dentine hypersensitivity. |
| 03/29/1995 | CN1100616A Filter core containing iodine for mineral water pot |
| 03/29/1995 | CA2117394A1 Biodegradable implant precursor |
| 03/28/1995 | US5401730 Method for reducing platelet aggregation |
| 03/28/1995 | US5401728 Containing plant oils, menthol, calcium stearate and magnesium stearate; for aiding in the transmission of nerve impulses |
| 03/28/1995 | US5401512 Antiulcer agents with 5-aminosalicylic acid with topical steroids |
| 03/28/1995 | US5401492 Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents |
| 03/25/1995 | WO1999013871A2 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |
| 03/23/1995 | WO1995007701A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 03/23/1995 | WO1995007691A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 03/23/1995 | WO1995007682A1 Oral compositions containing stannous compounds |
| 03/23/1995 | WO1995007630A1 Salt composition |
| 03/23/1995 | CA2171829A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 03/22/1995 | EP0643969A2 Pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis |
| 03/22/1995 | CN1100320A Dysphagia pills |
| 03/22/1995 | CN1100307A Polyvitmin active calcium and its preparing method |